2025年正子断层扫描（PET）放射性追踪剂全球市场报告

预计未来几年正子断层扫描（PET）放射性示踪剂的市场规模将强劲成长。到 2029 年，这一数字将成长至 36.3 亿美元，复合年增长率为 9.1%。预测期内的成长归因于应用范围的扩大、监管部门的核准、新兴市场的成长、老年人口的增加以及 PET 放射扫描仪的普及。预测期内的主要趋势包括微宠物技术的发展、与穿戴式技术的整合、治疗诊断学的扩展、奈米无线电示踪剂以及资料安全区块链。

预计未来几年感染疾病的增加将推动正子断层扫描 (PET) 放射性追踪剂市场的成长。感染疾病是由细菌、病毒、真菌和寄生虫等病原微生物引起的疾病。导致这些疾病传播的因素包括气候变迁、都市化、全球化、抗生素抗药性和人类行为的改变，所有这些都促进了病原体的传播。 PET 放射性追踪剂透过可视化代谢活动和炎症，帮助检测感染疾病、评估治疗反应、区分感染疾病和非感染疾病，在感染疾病管理中发挥重要作用，最终改善患者的预后。例如，2024年2月，英国政府机构英国卫生安全局报告称，2023年英格兰的结核病病例数将增加10.7%，报告病例数将达到4,850例，而2022年为4,380例。因此，感染疾病的流行正在推动PET放射性示踪剂市场的需求。

PET 放射性追踪剂市场的主要企业正专注于开发先进的诊断解决方案，例如可改善癌症检测和增强患者预后的 PET 造影剂。 PET 造影剂是放射性物质，用于在 PET 扫描期间观察和测量体内的生物过程。例如，2023年3月，加拿大放射性製药公司IsoLogic Innovative Radiopharmaceuticals在加拿大推出了Illuccix，又称Ga-68 Gozetotide Preparation Kit (PSMA-11)，作为前列腺癌成像剂，用于检测转移性前列腺癌。该工具对于帮助医生识别转移性疾病和做出明智的患者管理决策至关重要。其适用于接受初步确定性治疗的疑似转移患者和根据血清前列腺特异性抗原 (PSA) 水平升高而疑似復发的患者。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 世界正子断层扫描 (PET) 放射性追踪剂 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球正子断层扫描（PET）放射性示踪剂市场：成长率分析
• 全球 PET 放射性追踪剂市场表现：规模与成长，2019-2024 年
• 全球正子断层扫描 (PET) 放射性示踪剂市场预测：2024-2029 年及 2034 年规模与成长
• 全球正子断层扫描 (PET) 放射性示踪剂总目标市场 (TAM)

第六章市场区隔

• 全球 PET 放射性追踪剂市场（依放射性追踪剂类型、效能及预测），2019-2024 年、2024-2029 年、2034 年
• F-18（氟脱氧葡萄糖18）
• Ga-68（纤维母细胞活化蛋白抑制剂）
• 其他类型的放射性示踪剂
• 全球正子断层扫描 (PET) 放射性示踪剂市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 癌症
• 心臟病
• 胃肠道
• 内分泌
• 神经系统疾病
• 其他用途
• 全球正子断层扫描 (PET) 放射性示踪剂市场：按最终用户、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 医院
• 诊断中心
• 其他最终用户
• 全球正子断层扫描 (PET) 以氟脱氧葡萄糖-18 (F-18) 放射性示踪剂市场细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• F-18 FDG（氟脱氧葡萄糖）
• F-18 氟乙基酪胺酸 (FET)
• F-18 Florbetapir（淀粉样蛋白 PET 影像）
• 全球正子断层扫描 (PET) 放射性示踪剂市场 Ga-68（纤维母细胞活化蛋白抑制剂）细分市场类型、实际及预测，2019-2024 年、2024-2029 年、2034 年
• Ga-68dotatate（神经内分泌肿瘤成像）
• Ga-68 PSMA（前列腺特异性膜抗原成像）
• Ga-68 FAPI（纤维母细胞活化蛋白抑製成像）
• 全球正子断层扫描 (PET) 放射性示踪剂市场，按其他放射性示踪剂类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
• C-11（碳11）
• N-13（氮13）
• O-15（氧15）
• 铷-82（铷-82）
• I-124（碘-124）

第七章 区域和国家分析

• 全球 PET 放射性追踪剂市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球 PET 放射性追踪剂市场：依国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 正子断层扫描 (PET) 放射性示踪剂市场：竞争格局
• 正子断层扫描 (PET) 放射性示踪剂市场：公司简介
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Philips Healthcare
• Bracco Imaging SpA
• Neusoft Medical Systems Co. Ltd.
• Lantheus Holdings Inc.
• Jubilant Pharma Limited
• SOFIE Biosciences（SOFIE）
• Yantai Dongcheng Pharmaceutical Group Co. Ltd.
• Nordion Inc.
• RefleXion Medical Inc.
• Isologic Innovative Radiopharmaceuticals
• ABX Advanced Biochemical Compounds GmbH
• IBA Radiopharma Solutions SA
• IXICO PLC
• ImaginAb Inc.
• Radiomedix Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年正子断层扫描（PET）放射性追踪剂市场：提供新机会的国家
• 2029年正子断层扫描（PET）放射性追踪剂市场：细分市场带来新机会
• 正子断层扫描 (PET) 放射性示踪剂市场 2029 年：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

A positron emission tomography (PET) radiotracer is a radioactive substance used in PET imaging. This radiotracer is administered to a patient via injection, where it binds to specific biological targets, enabling the PET scanner to visualize metabolic activity and diagnose conditions such as cancer or neurological disorders.

The primary types of PET radiotracers include F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), and others. F-18 (Fluorodeoxyglucose 18) radiotracers are radioactive glucose analogs utilized in PET imaging to evaluate metabolic activity in tissues, particularly for cancer detection. These radiotracers are applied across various medical fields, including oncology, cardiology, gastrointestinal disorders, endocrine issues, and neurology. They are used by end-users such as hospitals and diagnostic centers, among others.

The positron emission tomography (PET) radiotracer market research report is one of a series of new reports from The Business Research Company that provides positron emission tomography (PET) radiotracer market statistics, including the positron emission tomography (PET) radiotracer industry's global market size, regional shares, competitors with a positron emission tomography (PET) radiotracer market share, detailed positron emission tomography (PET) radiotracer market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (PET) radiotracer industry. This positron emission tomography (PET) radiotracer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The positron emission tomography (PET) radiotracer market size has grown strongly in recent years. It will grow from $2.35 billion in 2024 to $2.57 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the increasing prevalence of infectious diseases, increasing awareness and accessibility, the emergence of novel radiotracers, the rising prevalence of cancer, and the increasing focus on preventive medicine.

The positron emission tomography (PET) radiotracer market size is expected to see strong growth in the next few years. It will grow to $3.63 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to the expansion of applications, regulatory approvals, growth in emerging markets, growing geriatric population, and growing adoption of PET radio scanners. Major trends in the forecast period include the development of micro-pet technology, integration with wearable technology, expansion of theranostics, nano-radiotracers, and blockchain for data security.

The anticipated rise in infectious diseases is projected to drive the growth of the positron emission tomography (PET) radiotracer market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites. Factors contributing to the increased prevalence of these diseases include climate change, urbanization, globalization, antibiotic resistance, and shifts in human behavior, all of which facilitate the spread of pathogens. PET radiotracers play a crucial role in managing infectious diseases by visualizing metabolic activity and inflammation, which aids in the detection of infections, assessment of treatment responses, and differentiation between infectious and non-infectious conditions, ultimately leading to improved patient outcomes. For example, in February 2024, a report from the UK Health Security Agency, a government agency in the UK, indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Hence, the growing prevalence of infectious diseases is driving demand for the PET radiotracer market.

Leading companies in the PET radiotracer market are concentrating on developing advanced diagnostic solutions, such as PET imaging agents that improve cancer detection and enhance patient outcomes. A PET imaging agent is a radioactive substance utilized to visualize and measure biological processes in the body during PET scans. For instance, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a Canadian radiopharmaceutical firm, launched Illuccix, also known as the Ga-68 Gozetotide Preparation Kit (PSMA-11), in Canada as a prostate cancer imaging agent aimed at detecting metastatic prostate cancer. This tool is crucial for physicians in identifying metastatic disease and making informed patient management decisions. It is indicated for patients suspected of metastasis who are candidates for initial definitive therapy, as well as for those with suspected recurrence indicated by elevated serum prostate-specific antigen (PSA) levels.

In February 2023, Lantheus Holdings Inc., a U.S.-based developer of diagnostic products, acquired Cerveau Technologies for an undisclosed sum. This acquisition is intended to enhance Lantheus Holdings' imaging pipeline, particularly for Alzheimer's disease diagnostics, by integrating Cerveau's MK-6240, a second-generation PET imaging agent that targets tau tangles in the brain. Cerveau Technologies Inc. is a U.S.-based provider of information and technology specializing in PET radiotracers.

Major companies operating in the positron emission tomography (PET) radiotracer market are Cardinal Health Inc., AstraZeneca PLC, Eli Lilly and Company, Siemens Healthineers AG, GE Healthcare Technologies Inc., Philips Healthcare, Bracco Imaging S.p.A., Neusoft Medical Systems Co Ltd., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences (SOFIE), Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., RefleXion Medical Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., IXICO PLC, ImaginAb Inc., Radiomedix Inc.

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the positron emission tomography (PET) radiotracer marker report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The positron emission tomography (PET) radiotracer market consists of sales of FDG (fluorodeoxyglucose), f-dopa (fluorodopa), C-11 methionine, C-11 methionine, F-18 naf (sodium fluoride), and C-11 choline. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Positron Emission Tomography (PET) Radiotracer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on positron emission tomography (pet) radiotracer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for positron emission tomography (pet) radiotracer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The positron emission tomography (pet) radiotracer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18); Ga-68 (Fibroblast Activation Protein Inhibitor); Other Radiotracer Types
• 2) By Application: Cancer; Heart Disease; Gastrointestinal; Endocrine; Neurological Disorders; Other Applications
• 3) By End-User: Hospitals; Diagnostic Centers; Other End-Users
• Subsegments:
• 1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose); F-18 Fluoroethyltyrosine (FET); F-18 Florbetapir (Amyloid PET Imaging)
• 2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging); Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging); Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
• 3) By Other Radiotracer Types: C-11 (Carbon-11); N-13 (Nitrogen-13); O-15 (Oxygen-15); Rb-82 (Rubidium-82); I-124 (Iodine-124)
• Companies Mentioned: Cardinal Health Inc.; AstraZeneca PLC; Eli Lilly and Company; Siemens Healthineers AG; GE Healthcare Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Positron Emission Tomography (PET) Radiotracer Market Characteristics

3. Positron Emission Tomography (PET) Radiotracer Market Trends And Strategies

4. Positron Emission Tomography (PET) Radiotracer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Positron Emission Tomography (PET) Radiotracer Growth Analysis And Strategic Analysis Framework

• 5.1. Global Positron Emission Tomography (PET) Radiotracer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Positron Emission Tomography (PET) Radiotracer Market Growth Rate Analysis
• 5.4. Global Positron Emission Tomography (PET) Radiotracer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Positron Emission Tomography (PET) Radiotracer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Positron Emission Tomography (PET) Radiotracer Total Addressable Market (TAM)

6. Positron Emission Tomography (PET) Radiotracer Market Segmentation

• 6.1. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• F-18 (Fluorodeoxyglucose 18)
• Ga-68 (Fibroblast Activation Protein Inhibitor)
• Other Radiotracer Types
• 6.2. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Heart Disease
• Gastrointestinal
• Endocrine
• Neurological Disorders
• Other Applications
• 6.3. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centers
• Other End-Users
• 6.4. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of F-18 (Fluorodeoxyglucose 18), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• F-18 FDG (Fluorodeoxyglucose)
• F-18 Fluoroethyltyrosine (FET)
• F-18 Florbetapir (Amyloid PET Imaging)
• 6.5. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Ga-68 (Fibroblast Activation Protein Inhibitor), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ga-68 Dotatate (Neuroendocrine Tumor Imaging)
• Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging)
• Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
• 6.6. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Other Radiotracer Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• C-11 (Carbon-11)
• N-13 (Nitrogen-13)
• O-15 (Oxygen-15)
• Rb-82 (Rubidium-82)
• I-124 (Iodine-124)

7. Positron Emission Tomography (PET) Radiotracer Market Regional And Country Analysis

• 7.1. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market

• 8.1. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Positron Emission Tomography (PET) Radiotracer Market

• 9.1. China Positron Emission Tomography (PET) Radiotracer Market Overview
• 9.2. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Positron Emission Tomography (PET) Radiotracer Market

• 10.1. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Positron Emission Tomography (PET) Radiotracer Market

• 11.1. Japan Positron Emission Tomography (PET) Radiotracer Market Overview
• 11.2. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Positron Emission Tomography (PET) Radiotracer Market

• 12.1. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Positron Emission Tomography (PET) Radiotracer Market

• 13.1. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Positron Emission Tomography (PET) Radiotracer Market

• 14.1. South Korea Positron Emission Tomography (PET) Radiotracer Market Overview
• 14.2. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Positron Emission Tomography (PET) Radiotracer Market

• 15.1. Western Europe Positron Emission Tomography (PET) Radiotracer Market Overview
• 15.2. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Positron Emission Tomography (PET) Radiotracer Market

• 16.1. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Positron Emission Tomography (PET) Radiotracer Market

• 17.1. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Positron Emission Tomography (PET) Radiotracer Market

• 18.1. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Positron Emission Tomography (PET) Radiotracer Market

• 19.1. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Positron Emission Tomography (PET) Radiotracer Market

• 20.1. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market

• 21.1. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market Overview
• 21.2. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Positron Emission Tomography (PET) Radiotracer Market

• 22.1. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Positron Emission Tomography (PET) Radiotracer Market

• 23.1. North America Positron Emission Tomography (PET) Radiotracer Market Overview
• 23.2. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Positron Emission Tomography (PET) Radiotracer Market

• 24.1. USA Positron Emission Tomography (PET) Radiotracer Market Overview
• 24.2. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Positron Emission Tomography (PET) Radiotracer Market

• 25.1. Canada Positron Emission Tomography (PET) Radiotracer Market Overview
• 25.2. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Positron Emission Tomography (PET) Radiotracer Market

• 26.1. South America Positron Emission Tomography (PET) Radiotracer Market Overview
• 26.2. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Positron Emission Tomography (PET) Radiotracer Market

• 27.1. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Positron Emission Tomography (PET) Radiotracer Market

• 28.1. Middle East Positron Emission Tomography (PET) Radiotracer Market Overview
• 28.2. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Positron Emission Tomography (PET) Radiotracer Market

• 29.1. Africa Positron Emission Tomography (PET) Radiotracer Market Overview
• 29.2. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape And Company Profiles

• 30.1. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape
• 30.2. Positron Emission Tomography (PET) Radiotracer Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Positron Emission Tomography (PET) Radiotracer Market Other Major And Innovative Companies

• 31.1. Philips Healthcare
• 31.2. Bracco Imaging S.p.A.
• 31.3. Neusoft Medical Systems Co. Ltd.
• 31.4. Lantheus Holdings Inc.
• 31.5. Jubilant Pharma Limited
• 31.6. SOFIE Biosciences (SOFIE)
• 31.7. Yantai Dongcheng Pharmaceutical Group Co. Ltd.
• 31.8. Nordion Inc.
• 31.9. RefleXion Medical Inc.
• 31.10. Isologic Innovative Radiopharmaceuticals
• 31.11. ABX Advanced Biochemical Compounds GmbH
• 31.12. IBA Radiopharma Solutions S.A.
• 31.13. IXICO PLC
• 31.14. ImaginAb Inc.
• 31.15. Radiomedix Inc.

32. Global Positron Emission Tomography (PET) Radiotracer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Radiotracer Market

34. Recent Developments In The Positron Emission Tomography (PET) Radiotracer Market

35. Positron Emission Tomography (PET) Radiotracer Market High Potential Countries, Segments and Strategies

• 35.1 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer